Clinical Trial Results:
Phase IIIb Multicenter, Single Arm, Open-label Pilot Study to Evaluate the Effectiveness and Safety of Maintenance with Atazanavir/ritonavir as Single Enhanced Protease Inhibitor Therapy in HIV-Infected Patients Evidencing Virologic Suppression.
Revised Protocol 01, incorporating Protocol Amendment 01 (Version 1.0, Date 19-Jan-2007).
Estudio piloto de fase IIIb, de un solo brazo, abierto y multicéntrico, para evaluar la eficacia y la seguridad del mantenimiento con atazanavir/ritonavir en monoterapia en pacientes infectados por el VIH que muestren supresión virológica. Protocolo Revisado 01, que incorpora la enmienda 01 al protocolo (v 1.0 de fecha 19-enero-2007).
Summary
|
|
EudraCT number |
2005-005119-76 |
Trial protocol |
ES |
Global completion date |
04 May 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Dec 2016
|
First version publication date |
24 Dec 2016
|
Other versions |
|
Summary report(s) |
AI424-227_Addendum_Synopsis AI424-227_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.